ACRIX
Price
$28.43
Change
+$0.10 (+0.35%)
Updated
Jun 2 closing price
Net Assets
1.61B
CLTAX
Price
$17.64
Change
+$0.01 (+0.06%)
Updated
Jun 2 closing price
Net Assets
16.97M
Interact to see
Advertisement

ACRIX vs CLTAX

Header iconACRIX vs CLTAX Comparison
Open Charts ACRIX vs CLTAXBanner chart's image
ACRIX vs CLTAX Comparison Chart in %
View a ticker or compare two or three
VS
ACRIX vs. CLTAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRIX is a StrongBuy and CLTAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACRIX has more cash in the bank: 1.61B vs. CLTAX (17M). ACRIX pays higher dividends than CLTAX: ACRIX (0.67) vs CLTAX (0.00). ACRIX was incepted earlier than CLTAX: ACRIX (10 years) vs CLTAX (14 years). CLTAX (2.09) is less costly to investors than ACRIX (1.15). ACRIX is a more actively managed with annual turnover of: 172.00 vs. CLTAX (69.00). CLTAX has a lower initial minimum investment than ACRIX: CLTAX (2500) vs ACRIX (10000000). ACRIX annual gain was more profitable for investors over the last year : 17.01 vs. CLTAX (14.48). ACRIX return over 5 years is better than : 15.71 vs. CLTAX (-4.41).
ACRIXCLTAXACRIX / CLTAX
Total Expense Ratio1.151.5375%
Annual Report Gross Expense Ratio1.152.0955%
Fund Existence10 years14 years-
Gain YTD12.46511.230111%
Front LoadN/A6%-
Min. Initial Investment100000002500400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.61B17M9,447%
Annual Yield % from dividends0.670.00-
Returns for 1 year17.0114.48117%
Returns for 3 years36.3731.39116%
Returns for 5 years15.71-4.41-356%
Returns for 10 yearsN/A39.22-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TKR131.905.36
+4.24%
Timken Company (The)
GNS0.26N/A
+1.91%
Genius Group Limited
OXLCN24.940.22
+0.89%
Oxford Lane Capital Corp
VET11.730.08
+0.69%
Vermilion Energy
FBRX18.17-1.06
-5.54%
Forte Biosciences Inc